Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1984 May;81(10):3204–3208. doi: 10.1073/pnas.81.10.3204

Autoantibodies to glucosylated proteins in the plasma of patients with diabetes mellitus.

J L Witztum, U P Steinbrecher, Y A Kesaniemi, M Fisher
PMCID: PMC345250  PMID: 6587346

Abstract

Nonenzymatic glucosylation interferes with recognition of low density lipoprotein (LDL) by its receptor and markedly decreases the rate of plasma clearance of glucosylated LDL, both in experimental animals and in normal human subjects. However, in selected diabetic subjects we have observed a paradoxical increase in the clearance of glucosylated LDL, suggesting the possibility of immune-mediated clearance. Immunoassay demonstrated antibodies specific for glucosylated LDL in the preinjection plasma of each of four such diabetic subjects studied. These antibodies cross-react with other glucosylated proteins and recognize specifically the glucosylated lysine epitope--i.e., glucitollysine . These data suggest that nonenzymatic glucosylation of plasma or structural proteins may render them immunogenic and result in production of autoantibodies that recognize not only the particular immunogen but also many other glucosylated proteins, including glucosylated tissue proteins. These findings may be relevant to the increased prevalence of immune complexes in plasma of diabetic subjects and the late complications of diabetes mellitus.

Full text

PDF
3204

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bauer B. J., Blashfield K., Norris R., Buthala D. A., Ginsberg L. C. Immunoglobulin as the major low density lipoprotein binding protein in plasma. Atherosclerosis. 1982 Aug;44(2):153–160. doi: 10.1016/0021-9150(82)90110-1. [DOI] [PubMed] [Google Scholar]
  2. Beaumont J. L., Beaumont V. Autoimmune hyperlipidemia. Atherosclerosis. 1977 Apr;26(4):405–418. doi: 10.1016/0021-9150(77)90111-3. [DOI] [PubMed] [Google Scholar]
  3. Bilheimer D. W., Grundy S. M., Brown M. S., Goldstein J. L. Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes. Proc Natl Acad Sci U S A. 1983 Jul;80(13):4124–4128. doi: 10.1073/pnas.80.13.4124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bodansky H. J., Wolf E., Cudworth A. G., Dean B. M., Nineham L. J., Bottazzo G. F., Matthews J. A., Kurtz A. B., Kohner E. M. Genetic and immunologic factors in microvascular disease in type I insulin-dependent diabetes. Diabetes. 1982 Jan;31(1):70–74. doi: 10.2337/diab.31.1.70. [DOI] [PubMed] [Google Scholar]
  5. Curtiss L. K., Witztum J. L. A novel method for generating region-specific monoclonal antibodies to modified proteins. Application to the identification of human glucosylated low density lipoproteins. J Clin Invest. 1983 Oct;72(4):1427–1438. doi: 10.1172/JCI111099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Flückiger R., Harmon W., Meier W., Loo S., Gabbay K. H. Hemoglobin carbamylation in uremia. N Engl J Med. 1981 Apr 2;304(14):823–827. doi: 10.1056/NEJM198104023041406. [DOI] [PubMed] [Google Scholar]
  7. Gorzynski T. J., David C. S. Immune-response gene-associated antigens (Ia/DR). Structure and function in immunologically related diseases. Mayo Clin Proc. 1983 Jul;58(7):457–466. [PubMed] [Google Scholar]
  8. Higgins P. J., Bunn H. F. Kinetic analysis of the nonenzymatic glycosylation of hemoglobin. J Biol Chem. 1981 May 25;256(10):5204–5208. [PubMed] [Google Scholar]
  9. Iavicoli M., Di Mario U., Pozzilli P., Canalese J., Ventriglia L., Galfo C., Andreani D. Impaired phagocytic function and increased immune complexes in diabetics with severe microangiopathy. Diabetes. 1982 Jan;31(1):7–11. doi: 10.2337/diab.31.1.7. [DOI] [PubMed] [Google Scholar]
  10. Irvine W. J., Di Mario U., Guy K., Feek C. M., Gray R. S., Duncan L. J. Immune complexes in newly diagnosed insulin-dependent (type I) diabetics. J Clin Lab Immunol. 1978 Nov;1(3):183–186. [PubMed] [Google Scholar]
  11. Irvine W. J., Di Mario U., Guy K., Iavicoli M., Pozzilli P., Lumbroso B., Andreani D. Immune complexes and diabetic microangiopathy. J Clin Lab Immunol. 1978 Nov;1(3):187–191. [PubMed] [Google Scholar]
  12. Kahn C. R., Mann D., Rosenthal A. S., Galloway J. A., Johnson A. H., Mendell N. The immune response to insulin in man. Interaction of HLA alloantigens and the development of the immune response. Diabetes. 1982 Aug;31(8 Pt 1):716–723. doi: 10.2337/diab.31.8.716. [DOI] [PubMed] [Google Scholar]
  13. Kesaniemi Y. A., Witztum J. L., Steinbrecher U. P. Receptor-mediated catabolism of low density lipoprotein in man. Quantitation using glucosylated low density lipoprotein. J Clin Invest. 1983 Apr;71(4):950–959. doi: 10.1172/JCI110849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Mauer S. M., Michael A. F., Fish A. J., Brown D. M. Spontaneous immunoglobulin and complement deposition in glomeruli of diabetic rats. Lab Invest. 1972 Nov;27(5):488–494. [PubMed] [Google Scholar]
  15. Plow E. F., Edgington T. S. Immune responses to the cleavage-associated neoantigens of fibrinogen in man. Identification and characterization of humoral antibodies specific for cleavage fragments. J Clin Invest. 1975 Dec;56(6):1509–1518. doi: 10.1172/JCI108232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Roberts-Thomson P. J., Venables G. S., Onitiri A. C., Lewis B. Polymeric IgA myeloma, hyperlipidaemia and xanthomatosis: a further case and review. Postgrad Med J. 1975 Jan;51(591):44–51. doi: 10.1136/pgmj.51.591.44. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Sasaki J., Okamura T., Cottam G. L. Measurement of receptor-independent metabolism of low-density lipoprotein. An application of glycosylated low-density lipoprotein. Eur J Biochem. 1983 Apr 5;131(3):535–538. doi: 10.1111/j.1432-1033.1983.tb07294.x. [DOI] [PubMed] [Google Scholar]
  18. Steinbrecher U. P., Witztum J. L. Glucosylation of low-density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism. Diabetes. 1984 Feb;33(2):130–134. doi: 10.2337/diab.33.2.130. [DOI] [PubMed] [Google Scholar]
  19. Steinbrecher U. P., Witztum J. L., Kesaniemi Y. A., Elam R. L. Comparison of glucosylated low density lipoprotein with methylated or cyclohexanedione-treated low density lipoprotein in the measurement of receptor-independent low density lipoprotein catabolism. J Clin Invest. 1983 Apr;71(4):960–964. doi: 10.1172/JCI110850. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Stevens V. J., Fantl W. J., Newman C. B., Sims R. V., Cerami A., Peterson C. M. Acetaldehyde adducts with hemoglobin. J Clin Invest. 1981 Feb;67(2):361–369. doi: 10.1172/JCI110043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Szondy E., Horváth M., Mezey Z., Székely J., Lengyel E., Füst G., Gerö S. Free and complexed anti-lipoprotein antibodies in vascular diseases. Atherosclerosis. 1983 Oct;49(1):69–77. doi: 10.1016/0021-9150(83)90008-4. [DOI] [PubMed] [Google Scholar]
  22. Taylor J. S., Lewis L. A., Battle J. D., Jr, Butkus A., Robertson A. L., Deodhar S., Roenigk H. H., Jr Plane xanthoma and multiple myeloma with lipoprotein--paraprotein complexing. Arch Dermatol. 1978 Mar;114(3):425–431. [PubMed] [Google Scholar]
  23. Urbanowski J. C., Cohenford M. A., Levy H. L., Crawford J. D., Dain J. A. Nonenzymatically galactosylated serum albumin in a galactosemic infant. N Engl J Med. 1982 Jan 14;306(2):84–86. doi: 10.1056/NEJM198201143060207. [DOI] [PubMed] [Google Scholar]
  24. Virella G., Wohltmann H., Sagel J., Lopes-Virella M. F., Kilpatrick M., Phillips C., Colwell J. Soluble immune complexes in patients with diabetes mellitus: detection and pathological significance. Diabetologia. 1981 Sep;21(3):184–191. doi: 10.1007/BF00252652. [DOI] [PubMed] [Google Scholar]
  25. Wardle E. N. An antibody to low density lipoprotein in diabetics. Experientia. 1978 Jul 15;34(7):886–887. doi: 10.1007/BF01939684. [DOI] [PubMed] [Google Scholar]
  26. Witztum J. L., Mahoney E. M., Branks M. J., Fisher M., Elam R., Steinberg D. Nonenzymatic glucosylation of low-density lipoprotein alters its biologic activity. Diabetes. 1982 Apr;31(4 Pt 1):283–291. doi: 10.2337/diab.31.4.283. [DOI] [PubMed] [Google Scholar]
  27. Witztum J. L., Steinbrecher U. P., Fisher M., Kesaniemi A. Nonenzymatic glucosylation of homologous low density lipoprotein and albumin renders them immunogenic in the guinea pig. Proc Natl Acad Sci U S A. 1983 May;80(9):2757–2761. doi: 10.1073/pnas.80.9.2757. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES